NM_145207.3:c.1664G>C
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_145207.3(AFG2A):c.1664G>C(p.Ser555Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_145207.3 missense
Scores
Clinical Significance
Conservation
Publications
- microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AFG2A | ENST00000274008.5 | c.1664G>C | p.Ser555Thr | missense_variant | Exon 9 of 16 | 1 | NM_145207.3 | ENSP00000274008.3 | ||
| AFG2A | ENST00000422835.2 | n.1706G>C | non_coding_transcript_exon_variant | Exon 9 of 15 | 1 | |||||
| AFG2A | ENST00000675612.1 | c.1661G>C | p.Ser554Thr | missense_variant | Exon 9 of 17 | ENSP00000502453.1 | ||||
| AFG2A | ENST00000674886.1 | n.1726G>C | non_coding_transcript_exon_variant | Exon 9 of 11 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461804Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727214 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Uncertain:2
This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 555 of the SPATA5 protein (p.Ser555Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SPATA5-related conditions. ClinVar contains an entry for this variant (Variation ID: 572155). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SPATA5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The variant is observed at an extremely low frequency in the gnomAD v4.1.0 dataset (total allele frequency: 0.001%). Damaging effect on gene or gene product predicted by in silico programs is uncertain [REVEL: 0.13 (damaging >=0.6, benign <0.4), 3Cnet: 0.52 (damaging >=0.6, benign <0.15)]. Therefore, this variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at